stockrow
Friday 6 November 2026
Export OPTH’s income statement to Excel — free account
Optimi Health Corp.
OPTH Healthcare Drug Manufacturers Specialty & Generic
Optimi Health Corp.’s revenue for fiscal 2025 (year ended September 2025) was $304,800.00, up 6.39% from fiscal 2024.
2.30
0.09
−3.77%
Follow OPTH
Alert me
| Sep '23 | Dec '23 | Sep '24 | Sep '25 | |
|---|---|---|---|---|
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | 76.62 | (1.43) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(6.43) | (6.43) | (6.50) | (9.95) |
P/Operating CF |
0.00 | 0.00 | 0.00 | (886.50) |
P/B ratio |
0.00 | 0.00 | 0.00 | 142.93 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 142.93 |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 |
EV/FCF |
0.00 | 0.00 | 0.00 | 0.00 |
Quick Ratio |
0.07 | 0.07 | 0.07 | 0.15 |
Current Ratio |
0.38 | 0.38 | 0.38 | 0.22 |
Net Debt/EBITDA |
0.02 | 0.02 | 0.02 | (0.67) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 23.72% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.55 |
Asset Turnover |
0.00 | 0.03 | 0.03 | 0.03 |
Operating CF/Net income |
0.00 | 0.00 | 0.71 | 0.71 |
Capex/Depreciation |
— | — | (0.18) | (0.09) |
Interest Coverage |
(11.45) | (11.45) | (11.78) | (8.67) |
| 0.00% | 25.56% | 86.01% | (45.23%) | |
| 0.00% | (41.48%) | (41.48%) | (24.61%) | |
ROIC |
(32.42%) | (32.42%) | (36.21%) | (35.59%) |
Return on Tangible Assets |
(53.44%) | (53.44%) | (53.44%) | (64.86%) |
Average Days of Receivables |
116.19 | 116.19 | 116.19 | 81.43 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 37.07% | 81.56% |
Selling, General and Administrative Expense of Revenue |
1,107.26% | 1,107.26% | 498.50% | 274.97% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 15.43% | 10.89% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.10 |
Operating CF per Share |
— | — | (0.04) | (0.59) |
Capex per Share |
— | — | 0.00 | (0.02) |
Free Cash Flow per Share |
— | — | (0.04) | (0.61) |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.26 |
Shareholders Equity per Share |
0.00 | 0.00 | 0.08 | 1.47 |
Interest Debt per Share |
— | — | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.00 | 0.08 | 1.47 |
Free Cash Flow |
— | — | (3.26) | (1.94) |
Working Capital |
(1.46) | (1.46) | (1.46) | (4.76) |
Capital Expenditures |
— | — | (0.11) | (0.06) |
Net Current Asset Value |
(2.75) | (2.75) | (2.75) | (4.87) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.39 | 0.21 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||
Depreciation/Fixed assets |
0.00 | 0.00 | 0.07 | 0.08 |
Cash ROIC |
0.00% | 0.00% | (45.81%) | (23.99%) |
Accounts Receivable Turnover |
0.00 | 3.14 | 3.14 | 3.83 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.42 |
Inventory Turnover |
0.00 | 0.13 | 0.13 | 0.80 |
Average Days of Payables |
0.00 | 0.00 | 2,831.05 | 1,026.75 |
Days of Inventory on Hand |
2,746.27 | 2,746.27 | 2,746.27 | 229.12 |
Average Receivables |
— | 0.09 | 0.09 | 0.08 |
Average Payables |
— | — | — | 0.84 |
Average Inventory |
— | 0.66 | 0.66 | 0.44 |
Average Assets |
— | 10.69 | 10.69 | 10.78 |
Average Common Equity |
— | (17.35) | (5.16) | 5.87 |
Columns are period end dates · fundamentals updated 2 Nov 2026